
You can purchase shares of IRulya Therapeutics (NASDAQ:IRLA) through any online brokerage.
Other companies in IRulya Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for IRulya Therapeutics to provide a consensus price target.
The stock price for IRulya Therapeutics (NASDAQ: IRLA) is $38.75 last updated November 11, 2026 at 7:28 AM EST.
There are no upcoming dividends for IRulya Therapeutics.
IRulya Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for IRulya Therapeutics.
IRulya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension...